Daxor corporation ceo and president michael feldschuh provides corporate update in letter to shareholders

Oak ridge, tn, march 04, 2025 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology today issued a corporate update in a letter to shareholders filed in its certified shareholder report on form n-csr on march 04, 2025 from ceo & president, michael feldschuh. dear fellow shareholder: "behind every overnight success is a decade of relentless work that nobody saw.
DXR Ratings Summary
DXR Quant Ranking